Release date: 2024-08-20 14:58:54 Article From: Lucius Laos Recommended: 120
Mitotane is specific for non-surgical adrenocortical carcinoma, hyperplasia, and tumor-induced cortisol hyperactivity, and its essence lies in the precise inhibition of adrenal cortex function.
There are various aspects that patients and healthcare professionals need to be aware of when using Mitotane to ensure the safety and effectiveness of the medication, and the potential central nervous system effects of using Mitotane are detailed below:
Mitotane may cause sedation, drowsiness, and vertigo, and requires regular monitoring of behavioral and neurologic conditions, as well as plasma levels, and an increased risk of toxicity beyond 20 mg/L.
Mitotane can cause hypothyroidism, and thyroid function should be checked if cognitive impairment is present.
Mitotane affects the ability to drive and operate machinery, and when there is an adverse reaction to the central system, it is strictly forbidden to drive or operate dangerous machinery, and if necessary, adjust the dosage of the drug or stop it.
In addition to the need to be aware of central nervous toxicity during the use of Mitotane, further attention should be paid to the patient's own condition after discontinuation of Mitotane.
Patients should be aware of the following after discontinuation of Mitotane:
Patients should continue to be monitored for changes in physical condition and biochemistry after discontinuation to ensure that there are no residual problems or risk of recurrence.
If the drug needs to be stopped, the dose should be gradually reduced until the drug is completely stopped under the guidance of a doctor to avoid rebound or aggravation caused by sudden discontinuation.
In order to ensure the therapeutic effect of Mitotane, patients should pay attention to the changes in their own symptoms and other precautions from the above aspects after stopping the drug.
Here are some other precautions for patients using Mitotane:
During the use of Mitotane, concomitant use with other drugs that may affect the function of the adrenal cortex should be avoided to avoid drug interactions.
Patients should maintain good lifestyle habits and attitudes to avoid the occurrence of overwork and stress situations to reduce further effects on adrenal cortex function.
In the event of an emergency (e.g., shock, severe trauma, infection, etc.), you should seek medical attention immediately and inform your doctor that you are using Mitotane so that you can adjust your treatment plan in a timely manner.
【Warm tips】When patients buy generic drugs, they should choose formal channels to ensure the quality and safety of the drugs. Avoid purchasing counterfeit products from informal sources.
Lung cancer is the most rapidly increasing malignant tumor with the fastest increasing morbidity and···【more】
Recommended:2012024-09-07
On November 14, 2024, the Committee for Medicinal Products for Human Use (CHMP) of the European Medi···【more】
Recommended:1582025-13-01
Recent advancements have reaffirmed the significance of liquid biopsy in the management of advanced ···【more】
Recommended:1562025-06-01
FDA Approves First Generic Version of Victoza (liraglutide injection)The U.S. Food and Drug Administ···【more】
Recommended:1712024-30-12
The new indication involves the treatment of adult patients with locally advanced, unresectable non-···【more】
Recommended:1612024-24-12
he U.S. Food and Drug Administration (FDA) has approved Crenessity (crinecerfont) for use in combina···【more】
Recommended:1462024-17-12
In the phase Ib/II multicenter pivotal FELIX study, the autologous 41BB-ζ anti-CD19 chimeric antigen···【more】
Recommended:1052024-13-12
On 25 July 2024, the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHM···【more】
Recommended:2482024-26-08
Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address:No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Whatsapp: